Cytek BioSciences

CTKB

NASDAQHealth Care

Income Statement

Total Revenue$197.05M

Gross Profit$108.25M

Operating Income$0

EBITDA$0

EBIT$-24.76M

Pre-tax Income$-7.97M

Net Income$-11.25M

Net Cash$194.97M

Cash Equivalent$265.61M

Total Debt$4.91M

Net Debt$-190.06M

Book Value$395.74

Net Cash Per Share1530000.00

Book Value Per Share3.06

Return on Equity (ROE)-1.52%

Return on Assets (ROA)-1.21%

Return on Invested Capital (ROI)-1.50%

Net Profit Margin-3.00%

Current Ratio5.86

Quick Ratio5.03

Long-Term Debt / Equity0.00